@article{b6e15476e3dc403b9bfc677749c8b3c3,
title = "Human leukocyte antigen DRB1*04:05 and clozapine-induced agranulocytosis/granulocytopenia",
author = "\{Clozapine Pharmacogenomics Consortium of Japan (CPC-J)\} and Takeo Saito and Masashi Ikeda and Taisei Mushiroda and Nakao Iwata",
note = "Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: This work was supported by the Strategic Research Program for Brain Sciences (SRPBS) from the Japan Agency for Medical Research and Development (AMED) under Grant Number JP19dm0107097; GRIFIN of P3GM from AMED under Grant Numbers JP19km0405201 and JP19km0405208; JSPS Kakenhi Grant Numbers JP16H05378, JP17H04251 and JP18K15497; the Private University Research Branding Project from MEXT; SEISHIN Medical Research Foundation, Japan. Funding Information: The author(s) disclosed receipt of the following financial support for the research, authorship and/or publication of this article: This work was supported by the Strategic Research Program for Brain Sciences (SRPBS) from the Japan Agency for Medical Research and Development (AMED) under Grant Number JP19dm0107097; GRIFIN of P3GM from AMED under Grant Numbers JP19km0405201 and JP19km0405208; JSPS Kakenhi Grant Numbers JP16H05378, JP17H04251 and JP18K15497; the Private University Research Branding Project from MEXT; SEISHIN Medical Research Foundation, Japan.",
year = "2020",
month = may,
day = "1",
doi = "10.1177/0004867419900296",
language = "English",
volume = "54",
pages = "545--546",
journal = "Australian and New Zealand Journal of Psychiatry",
issn = "0004-8674",
publisher = "SAGE Publications Ltd",
number = "5",
}
SDG 3 すべての人に健康と福祉を